BlackRock Group Form 8.3 - Willis Towers Watson Plc (9352C)
22 Octubre 2020 - 9:20AM
UK Regulatory
TIDM0Y4Q
RNS Number : 9352C
BlackRock Group
22 October 2020
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing BlackRock, Inc.
(Note 1)
Company dealt in Willis Towers Watson plc
========================
Class of relevant security US$0.000304635 ordinary
to which the dealings shares
being disclosed relate
(Note 2)
========================
Date of dealing 21 October 2020
========================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
=========== ======= =========== ======
(1) Relevant securities 9,187,964 (7.13%) 3,898 (0.00%)
==================== ===================
(2) Derivatives (other
than options) 1,973,914 (1.53%) 4,692 (0.00%)
==================== ===================
(3) Options and agreements
to purchase/sell 0 (0.00%) 0 (0.00%)
==================== ===================
Total 11,161,878 (8.66%) 8,590 (0.00%)
==================== ===================
(b) Interests and short positions in relevant securities of the
company, other than the class dealt
in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
========= ====== =========== ======
(1) Relevant securities
=================== =====================
(2) Derivatives (other
than options)
=================== =====================
(3) Options and agreements
to purchase/sell
=================== =====================
Total
=================== =====================
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(Note 5)
Purchase 216 USD 209.3700
====================================== ====================
Purchase 197 USD 209.9594
====================================== ====================
Purchase 112 USD 210.1242
====================================== ====================
Purchase 405 USD 210.1333
====================================== ====================
Purchase 1,242 USD 210.1766
====================================== ====================
Purchase 8 USD 210.3138
====================================== ====================
Purchase 26 USD 210.4825
====================================== ====================
Purchase 30 USD 211.8800
====================================== ====================
Sale 3,149 USD 209.3700
====================================== ====================
Sale 36 USD 210.4225
====================================== ====================
Please note: there was also a Transfer Out of 5,175 Shares
(b) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 6) securities unit
e.g. CFD (Note 7) (Note 5)
CFD Reducing Short 22 USD 210.1236
===================== ================== ============
CFD Reducing Short 90 USD 210.1498
===================== ================== ============
CFD Reducing Short 746 USD 210.2424
===================== ================== ============
CFD Reducing Short 1 USD 210.8200
===================== ================== ============
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 5)
etc. relates (Note
7)
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
(d) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to
the
voting rights of any relevant securities under any option
referred to on this form or relating to
the voting rights or future acquisition
or disposal of any relevant securities to which any derivative
referred to on this form is referenced. If
none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 22 October 2020
Contact name Jana Blumenstein
================
Telephone number +44 20 7743 3650
================
If a connected EFM, name
of offeree/offeror with
which connected
================
If a connected EFM, state
nature of connection (Note
10)
================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ISEUUORRRUURUAA
(END) Dow Jones Newswires
October 22, 2020 10:20 ET (14:20 GMT)
Willis Towers Watson (LSE:0Y4Q)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Willis Towers Watson (LSE:0Y4Q)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
